Zymeworks (ZYME)
(Delayed Data from NSDQ)
$8.98 USD
-0.14 (-1.54%)
Updated May 20, 2024 04:00 PM ET
After-Market: $8.97 -0.01 (-0.11%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Zymeworks Inc. [ZYME]
Reports for Purchase
Showing records 41 - 55 ( 55 total )
Company: Zymeworks Inc.
Industry: Medical - Biomedical and Genetics
Company: Zymeworks Inc.
Industry: Medical - Biomedical and Genetics
Emphasis on ZW25 Misses the Mark: Target Lowered to $54
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Zymeworks Inc.
Industry: Medical - Biomedical and Genetics
ZW49 Is Upon Us; Expectations for the July 8, 2020, Update
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Zymeworks Inc.
Industry: Medical - Biomedical and Genetics
We are initiating coverage with a BUY rating and a 12-month target price of $70.00
Provider: Bloom Burton & Company
Analyst: MARTIN D
Company: Zymeworks Inc.
Industry: Medical - Biomedical and Genetics
Company: Zymeworks Inc.
Industry: Medical - Biomedical and Genetics
Company: Zymeworks Inc.
Industry: Medical - Biomedical and Genetics
All Quiet on the Western Front; Mid Year ZW49 Update the Key Focus; Reducing Target to $60
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Zymeworks Inc.
Industry: Medical - Biomedical and Genetics
From TINA to Cash Is King and Other Musings
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Zymeworks Inc.
Industry: Medical - Biomedical and Genetics
ZW25 + Tislelizumab + Chemo Following in the Footsteps KEYNOTE-811
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Zymeworks Inc.
Industry: Medical - Biomedical and Genetics
Runners up Is the New Killing It, and Other Tidbits
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Zymeworks Inc.
Industry: Medical - Biomedical and Genetics
LetÂ’s Caucus, or Never Again; In an Otherwise Ho-Hum Earnings Week
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Zymeworks Inc.
Industry: Medical - Biomedical and Genetics
Model Updates Post Secondary and Thoughts on Recent ZW25 and ZW49 Disclosures
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Zymeworks Inc.
Industry: Medical - Biomedical and Genetics
2020 Catalyst Calendar and Top Picks Across Mid, Small, and Micro Caps
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: Zymeworks Inc.
Industry: Medical - Biomedical and Genetics
Competition Is Good; But Not Perfect; Biparatopics Could Provide a Work-Around
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D